ICI Tx in MS Patients With Comorbid Cancer: Reassuring Data

There is no increased relapse risk in patients with multiple sclerosis and comorbid cancer who are taking checkpoint inhibitor therapy, results of a small study suggest.

Related Keywords

Massachusetts , United States , Boston , Jordan , American , Prashanth Rajarajan , Department Of Neurology , Harvard Medical School , American Academy Of Neurology , Medscape Medical , American Academy , Medscape Medical News , Justin Jordan , Massachusetts General Hospital , Multiple Sclerosis Ms , S Multiple Sclerosis , Cancer , Alignant Neoplasia , Arcinoma , Alignant Neoplasm , Biologic Therapy , Iologics , Skin Cancer , Alignant Skin Neoplasm , Lung Cancer , Ung Carcinoma , Ancer Of The Lung , Malignant Head And Neck Neoplasm , Head And Neck Cancer , Ead And Neck Cancer Hnc , Toxicology , Toxicity , Poisoning , Toxins , Autoimmune Disease ,